Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.46 |
| ▸ | PNMT | P11086 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 8/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 8/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.43 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.40 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.40 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | AGXT | P21549 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26656051 | 0.94 | OPRM1 (0.46) | TAAR1PNMTTSHRRECQLOPRM1 | |
| SCHEMBL11466186 | 0.79 | TSHR (0.53) | TAAR1PNMTTSHRRECQLAOC3 | |
| SCHEMBL31500392 | 0.79 | TSHR (0.53) | TAAR1PNMTTSHRRECQLAOC3 | |
| SCHEMBL21902246 | 0.78 | TSHR (0.51) | TAAR1PNMTTSHRRECQLAOC3 | |
| SCHEMBL21902239 | 0.78 | TSHR (0.51) | TAAR1PNMTTSHRRECQLAOC3 | |
| SCHEMBL12993155 | 0.76 | PYCR1 (0.56) | TAAR1PNMTTSHRRECQLAOC3 | |
| SCHEMBL21902245 | 0.75 | TSHR (0.49) | TAAR1PNMTTSHRRECQLAOC3 | |
| SCHEMBL26658419 | 0.75 | TAAR1 (0.47) | TAAR1PNMTTSHRRECQLOPRM1 | |
| SCHEMBL26658416 | 0.75 | TAAR1 (0.47) | TAAR1PNMTTSHRRECQLOPRM1 | |
| Hydrochloric Acid SCHEMBL30606538 | 0.74 | TAAR1 (0.46) | TAAR1PNMTTSHRRECQLOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023203254-A2 | EFFECTIVE MEANS TO MODULATE NMDA RECEPTOR-MEDIATED TOXICITY | FUNDAMENTAL PHARMA GMBH (DE) | 2023-10-26 | — | — | WO | disclosed |